Skip to main content
Log in

Self-Administration in the Pharmacological Treatment of Impotence

  • Practical Therapeutic
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Recent innovative research into the physiology and pharmacology of erection and the introduction of intracavernous injection of vasoactive agents have revolutionised our approach to the diagnosis and treatment of impotence. A thorough understanding of the rationale, indications, precautions and potential complications of intracavernous self-injection is essential for successful management.

The commonly used drugs for injection are papaverine, either alone or in combination with phentolamine, and alprostadil (prostaglandin E1). The major adverse effects include priapism, prolonged erection, and fibrosis of the erectile tissue. With the proper technique and appropriate dosage, this is a safe, minimally invasive, and highly effective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aboseif SR, Breza J, Bosch RJLH, Bernard F, Stief CG, et al. Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates. Journal of Urology 142: 403–408, 1989

    PubMed  CAS  Google Scholar 

  • Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. British Journal of Psychiatry 143: 332–337, 1983

    Article  PubMed  CAS  Google Scholar 

  • Ishii N, Watanabe H, Irisawa C, Kikuchi Y, Kawamura S, et al. Studies on male sexual impotence. Report 18: therapeutic trial with prostaglandin E1 for organic impotence. Japanese Journal of Urology 77: 954–962, 1986

    PubMed  CAS  Google Scholar 

  • Juenemann KP, Lue TF, Fournier Jr GR, Tanagho EA. Hemodynamics of papaverine-and phentolamine-induced penile erection. Journal of Urology 136: 158–161, 1986

    PubMed  CAS  Google Scholar 

  • Keogh EJ, Watters GR, Earle CM, Carati CJ, Wisniewski ZS, et al. Treatment of impotence by intrapenile injections. A comparison of papaverine and phentolamine: a double-blind, crossover trial. Journal of Urology 142: 726–728, 1989

    CAS  Google Scholar 

  • Robinson LQ, Stephenson TP. Self injection treatment for impotence. British Medical Journal 299: 1568, 1989

    Article  PubMed  CAS  Google Scholar 

  • Sidi AA, Cameron JS, Duffy LM, Lange P. Intracavernous drug induced erection in the management of male erectile dysfunction: experience with 100 patients. Journal of Urology 135: 704–706, 1986

    PubMed  CAS  Google Scholar 

  • Sidi AA, Cameron JS, Duffy LM, Lange P. Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence. Journal of Urology 140: 293–294, 1988

    PubMed  CAS  Google Scholar 

  • Stackl W, Hasun R, Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. Journal of Urology 140: 66–68, 1988

    PubMed  CAS  Google Scholar 

  • Virag R. Intracavernous injection of papaverine for erectile failure. Correspondence. Lancet 2: 938, 1982

    Article  CAS  Google Scholar 

  • Zorgniotti AW, Lefleur RS. Auto-injection of corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. Journal of Urology 133: 39–41, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bénard, F., Lue, T.F. Self-Administration in the Pharmacological Treatment of Impotence. Drugs 39, 394–398 (1990). https://doi.org/10.2165/00003495-199039030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199039030-00006

Keywords

Navigation